Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

novartis_side_building

Novartis’ top lawyer retires from role over botched Trump deal

May 16, 2018 Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma

The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …
News

Pfizer scores approval for first Epogen/Procrit biosimilar in the US

May 16, 2018 Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …
News
cold

How to treat colds? Target the person, not the virus

May 15, 2018 Research and Development biotech, common cold, drugs, pharma, pharmaceutical

Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …
News
dialogo

DIA: Pharmacovigilance conference

May 15, 2018 Medical Communications, Research and Development dia

We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …
News
shutterstock_159488225

New cancer clinical trial model promises to cut costs and development time

May 15, 2018 Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, Cancer, MD AndersonCancer Center, clinical trials, pharma

Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …
News
mosquito-49141_960_720

Smell test targets asymptomatic malaria carriers

May 15, 2018 Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …
News

Bringing the PRO to fruition

May 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
Feature
shutterstock_273326141

Medigene and bluebird bio expand immunotherapy partnership to $1.5bn

May 14, 2018 Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma

Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …
News
webinar

Free webinar: EU risk management for oncology medicines

May 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, dia

News
david_horn_solomon

Akari CEO resigns over allegations of spending company funds

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …
Appointment
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
News
roche

Roche’s Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer

May 11, 2018 Medical Communications, Research and Development Cancer, Cotellic, Roche, pharma, tecentriq

Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people …
News

AZ’s Fasenra stumbles in P3 for COPD

May 11, 2018 Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …
News
andy_c4

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …
Appointment
cancer-vs-alzheimer-1080x810

NanoBots: The science of small to dwarf the disease

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …
Feature
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026